George Adi Mor

Chief Scientific Officer at Chemomab Therapeutics Ltd. American Depositary Share

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
8 months
Director since
2026

8 months of board service in total across 1 board, counting each seat separately. Longest: Chemomab Therapeutics Ltd. American Depositary Share, 8 months.

Chemomab Therapeutics Ltd. American Depositary Share Director · Chief Executive Officer
8 months · Since 2026

Chief executive roles

Since March 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
May 29, 2026 Chemomab Therapeutics Ltd. American Depositary Share Open-market purchase −4,878 $2.05 $10,000
May 29, 2026 Chemomab Therapeutics Ltd. American Depositary Share Open-market purchase −4,926 $2.08 $10,246
May 29, 2026 Chemomab Therapeutics Ltd. American Depositary Share Other −31,712 — —
May 29, 2026 Chemomab Therapeutics Ltd. American Depositary Share Other −18,750 — —
Jan 3, 2023 Chemomab Therapeutics Ltd. American Depositary Share Open-market sale −7,700 $5.03 $38,731
Jan 3, 2023 Chemomab Therapeutics Ltd. American Depositary Share Open-market sale −6,100 $5.03 $30,683

Questions about George Adi Mor

What boards is George Adi Mor on?

George Adi Mor sits on the board of Chemomab Therapeutics Ltd. American Depositary Share.

What company is George Adi Mor the CEO of?

George Adi Mor has been Chief Executive Officer of Chemomab Therapeutics Ltd. American Depositary Share since March 2026.

How long has George Adi Mor served on boards?

Our records show at least 8 months of board service across 1 board, the earliest from 2026.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.